Marker Therapeutics Inc. (NASDAQ: MRKR)
$5.85
+0.0001 ( 0% ) 8.0K
Marker Therapeutics Inc is a clinical-stage immuno-oncology company specializing in the development and commercialization of novel T cell-based immunotherapies and innovative peptide-based vaccines for the treatment of hematological malignancies and solid tumor indications. The company develops product candidates from its MultiTAA T cell technology, which is based on the selective expansion of non-engineered, tumor-specific T cells that recognize tumor-associated antigens, or TAAs, which are tumor targets, and then kill tumor cells expressing those targets. It is also developing peptide-based immunotherapeutic vaccines for the treatment of metastatic solid tumors, as well as PolyStart.
Market Data
Open
$5.85
Previous close
$5.85
Volume
8.0K
Market cap
$51.09M
Day range
$5.79 - $6.15
52 week range
$2.40 - $9.68
SEC Fillings
Form Type | Description | Pages | Date |
---|---|---|---|
8-k | 8K-related | 13 | Jun 12, 2024 |
8-k | 8K-related | 21 | May 15, 2024 |
10-q | Quarterly Reports | 65 | May 15, 2024 |
def | Proxies and info statements | 6 | Apr 26, 2024 |
ars | Annual reports | 1 | Apr 26, 2024 |
8-k | 8K-related | 15 | Apr 08, 2024 |
10-k | Annual reports | 92 | Mar 26, 2024 |
8-k | 8K-related | 15 | Mar 26, 2024 |
8-k | 8K-related | 14 | Mar 01, 2024 |
8-k | 8K-related | 14 | Feb 26, 2024 |